Amedisys, Inc. (AMED)
Aug 14, 2025 - AMED was delisted (reason: acquired by UNH)
100.99
+0.01 (0.01%)
Inactive · Last trade price on Aug 14, 2025
Amedisys Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 2,402 | 2,348 | 2,236 | 2,223 | 2,214 | 2,072 | |
Revenue Growth | 4.92% | 5.00% | 0.59% | 0.41% | 6.88% | 5.93% |
Cost of Revenue | 1,365 | 1,331 | 1,246 | 1,260 | 1,233 | 1,185 |
Gross Profit | 1,038 | 1,018 | 990.87 | 962.77 | 980.76 | 886.15 |
Selling, General & Admin | 793.48 | 790.11 | 780.06 | 754.06 | 711.24 | 668.3 |
Operating Expenses | 811.64 | 808.11 | 797.81 | 778.99 | 742.14 | 697.1 |
Operating Income | 226.03 | 209.57 | 193.07 | 183.78 | 238.62 | 189.05 |
Interest Expense | -27.59 | -30.76 | -31.27 | -22.23 | -9.53 | -11.04 |
Interest & Investment Income | 10.66 | 8.11 | 3.27 | 0.18 | 0.05 | 0.29 |
Earnings From Equity Investments | 7.28 | 6.27 | 10.76 | -0.05 | 36.05 | 0.99 |
Other Non Operating Income (Expenses) | 11.21 | 8.07 | 6.47 | 1.57 | 1.75 | 1.31 |
EBT Excluding Unusual Items | 227.59 | 201.25 | 182.3 | 163.25 | 266.93 | 180.6 |
Merger & Restructuring Charges | -77.12 | -66.64 | -142.67 | - | - | - |
Asset Writedown | -49.27 | -48.39 | - | -3.01 | - | -4.15 |
Other Unusual Items | - | - | - | - | 13.3 | 34.37 |
Pretax Income | 149.29 | 86.22 | 39.62 | 160.24 | 280.23 | 210.82 |
Income Tax Expense | 67.42 | 48.05 | 50.56 | 42.55 | 70.07 | 25.64 |
Earnings From Continuing Operations | 81.87 | 38.16 | -10.94 | 117.7 | 210.17 | 185.18 |
Net Income to Company | 81.87 | 38.16 | -10.94 | 117.7 | 210.17 | 185.18 |
Minority Interest in Earnings | 3.76 | 5.07 | 1.19 | 0.91 | -1.09 | -1.58 |
Net Income | 85.63 | 43.23 | -9.75 | 118.61 | 209.07 | 183.61 |
Net Income to Common | 85.63 | 43.23 | -9.75 | 118.61 | 209.07 | 183.61 |
Net Income Growth | -6.91% | - | - | -43.27% | 13.87% | 44.76% |
Shares Outstanding (Basic) | 33 | 33 | 33 | 33 | 33 | 33 |
Shares Outstanding (Diluted) | 33 | 33 | 33 | 33 | 33 | 33 |
Shares Change | 1.10% | 1.39% | -0.17% | -0.97% | -0.89% | 0.84% |
EPS (Basic) | 2.61 | 1.32 | -0.30 | 3.65 | 6.40 | 5.64 |
EPS (Diluted) | 2.58 | 1.31 | -0.30 | 3.63 | 6.34 | 5.52 |
EPS Growth | -8.17% | - | - | -42.74% | 14.85% | 43.75% |
Additional Metrics
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Free Cash Flow | 235.02 | 215.12 | 131.57 | 127.12 | 182.59 | 283.62 |
Free Cash Flow Per Share | 7.08 | 6.51 | 4.04 | 3.89 | 5.54 | 8.53 |
Gross Margin | 43.19% | 43.34% | 44.31% | 43.31% | 44.30% | 42.78% |
Operating Margin | 9.41% | 8.92% | 8.63% | 8.27% | 10.78% | 9.13% |
Profit Margin | 3.56% | 1.84% | -0.44% | 5.33% | 9.44% | 8.86% |
Free Cash Flow Margin | 9.78% | 9.16% | 5.88% | 5.72% | 8.25% | 13.69% |
EBITDA | 253.06 | 235.61 | 216.91 | 208.72 | 269.52 | 217.85 |
EBITDA Margin | 10.53% | 10.03% | 9.70% | 9.39% | 12.17% | 10.52% |
D&A For EBITDA | 27.03 | 26.04 | 23.85 | 24.94 | 30.9 | 28.8 |
EBIT | 226.03 | 209.57 | 193.07 | 183.78 | 238.62 | 189.05 |
EBIT Margin | 9.41% | 8.92% | 8.63% | 8.27% | 10.78% | 9.13% |
Effective Tax Rate | 45.16% | 55.74% | 127.60% | 26.55% | 25.00% | 12.16% |
Advertising Expenses | - | 7.4 | 7.2 | 7.3 | 7.4 | 6.5 |